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E V I D E N C E - B A S E D A N S W E R
C L I N I C A L C O M M E N TA R Y
Multiple randomized controlled trials (RCTs)
demonstrate the effectiveness of both allergen
immunotherapy and antihistamines, with or
without nasal steroids, in the treatment of
seasonal allergic rhinitis (strength of recom-
mendation [SOR]: A). No RCTs directly
compare immunotherapy with conservative
management. Treatment decisions are driven
by the clinical presentation, patient and
physician preferences, practice guidelines,
and expert opinion1 (SOR: C, based on
expert opinion). In standard practice,
immunotherapy is not recommended for
most patients with seasonal allergic rhinitis.
Usually there’s an acceptable treatment
alternative with better symptom control
or fewer side effects 
When patients ask me about allergy shots,
I ask them to tell me about their concerns
about their allergies and experiences with
previous treatments. Often I find that they
do not really want shots, but just want to
feel better! Usually you can find an accept-
able treatment alternative, one with better
symptom control or fewer side effects.
When patients are referred for
immunotherapy, it’s important for them to
have realistic expectations. The initial
process involves weekly visits, and it may
take years to gain adequate symptom 
control. For patients with the commitment,
time, and insurance coverage, however,
the outcomes can be very positive.
Mary M. Stephens, MD, MPH
East Tennessee State University, Kingsport
z Evidence summary
A 2002 Agency for Healthcare Research
and Quality systematic review on the diag-
nosis and treatment of allergic rhinitis
found no RCTs comparing antihistamines
or nasal corticosteroids with immunother-
apy.2 Our literature review found 4 studies
not included in this report that compared
immunotherapy with nasal steroids or oral
antihistamines.3–6 Only 2 of these exam-
ined patient-oriented outcomes and both
are of poor quality.3,6 One study reported
that inhaled nasal steroid therapy was
superior to a nonstandard immunotherapy
for ragweed pollen–induced rhinitis.3 The
second study allowed patients to choose a
treatment arm; it found that immuno-
therapy was superior to treatment with
antihistamines and nasal steroids for
patients who chose it.6
For patients requiring medication,
studies comparing antihistamines with
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nasal corticosteroids have documented the
superiority of intranasal steroids for symp-
tom control of allergic rhinitis.2,7
The effectiveness of immunotherapy
has been documented in more than 40
placebo-controlled trials. However, the
patients involved in these trials were often
concurrently treated with allergy medica-
tions.8 In standard practice, immunothera-
py is not recommended for most patients
with seasonal allergic rhinitis unless avoid-
ance measures and symptomatic therapy
are ineffective, have adverse effects, or are
not feasible.9 Studies indicate that
immunotherapy is effective for several
years after treatment is discontinued.10
A review of recent placebo-con-
trolled trials indicates that the risk of
developing asthma among patients with
allergic rhinoconjunctivitis is significant-
ly reduced when patients receive specific
immunotherapy.11 However, allergy
immunotherapy presents risk of systemic
reactions, with one study reporting a
0.5% risk of systemic reactions per year
of therapy.12
Recommendations from others
The American College of Allergy, Asthma,
and Immunology recommends that effec-
tive management of allergic rhinitis may
require combinations of medications—
antihistamines, decongestants, nasal corti-
costeroids, and anticholinergic agents as
well as aggressive avoidance of rhinitis
triggers. Consider allergen immunotherapy
in carefully selected patients in consulta-
tion with an allergist-immunologist.10
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For most patients
there is 
an acceptable
alternative to 
allergy shots, with
better symptom
control and fewer
side effects
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